Testing effectiveness (Phase 2)Study completedNCT02675465
What this trial is testing
First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221
Who this might be right for
Pompe Disease
Amicus Therapeutics 29